Profil
Jim Harris was the founder of Polycore Therapeutics, Inc. and held the title of Chairman.
Postes actifs de Jim Harris
| Sociétés | Poste | Début |
|---|---|---|
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | Health Technology |
